BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,422,353 | -25.2% | 366,833 | -5.8% | 0.00% | 0.0% |
Q2 2023 | $24,616,149 | +2.8% | 389,496 | -26.8% | 0.00% | -33.3% |
Q1 2023 | $23,949,392 | +17.4% | 532,327 | +14.3% | 0.00% | +50.0% |
Q4 2022 | $20,394,826 | -79.9% | 465,529 | -69.8% | 0.00% | -85.7% |
Q3 2022 | $101,451,000 | +20.9% | 1,539,708 | -7.3% | 0.01% | +27.3% |
Q2 2022 | $83,887,000 | +485.0% | 1,660,792 | +639.9% | 0.01% | +450.0% |
Q1 2022 | $14,339,000 | -3.8% | 224,475 | +61.3% | 0.00% | 0.0% |
Q4 2021 | $14,909,000 | +7.5% | 139,177 | +3.2% | 0.00% | 0.0% |
Q3 2021 | $13,866,000 | -70.6% | 134,883 | -74.8% | 0.00% | -66.7% |
Q2 2021 | $47,098,000 | +681.3% | 535,446 | +763.6% | 0.01% | +500.0% |
Q1 2021 | $6,028,000 | -77.1% | 62,001 | -73.5% | 0.00% | -75.0% |
Q4 2020 | $26,269,000 | +321.2% | 234,241 | +248.2% | 0.00% | +300.0% |
Q3 2020 | $6,236,000 | +5.1% | 67,278 | -11.5% | 0.00% | 0.0% |
Q2 2020 | $5,931,000 | +33.9% | 76,040 | +0.4% | 0.00% | 0.0% |
Q1 2020 | $4,430,000 | -51.3% | 75,751 | -33.2% | 0.00% | -50.0% |
Q4 2019 | $9,092,000 | +165.9% | 113,484 | +143.8% | 0.00% | +100.0% |
Q3 2019 | $3,419,000 | -35.3% | 46,542 | -17.0% | 0.00% | 0.0% |
Q2 2019 | $5,287,000 | +75.1% | 56,048 | +48.6% | 0.00% | 0.0% |
Q1 2019 | $3,020,000 | -76.7% | 37,726 | -84.3% | 0.00% | -75.0% |
Q4 2018 | $12,981,000 | +42.8% | 240,813 | +106.7% | 0.00% | +100.0% |
Q3 2018 | $9,093,000 | -61.6% | 116,482 | -68.8% | 0.00% | -66.7% |
Q2 2018 | $23,705,000 | +38.0% | 373,422 | +99.4% | 0.01% | +20.0% |
Q1 2018 | $17,175,000 | -33.8% | 187,297 | -45.5% | 0.01% | -28.6% |
Q4 2017 | $25,937,000 | +520.7% | 343,955 | +473.4% | 0.01% | +600.0% |
Q3 2017 | $4,179,000 | +71.9% | 59,983 | +25.0% | 0.00% | 0.0% |
Q2 2017 | $2,431,000 | -69.5% | 47,980 | -75.9% | 0.00% | 0.0% |
Q1 2017 | $7,972,000 | +50.4% | 199,336 | +5.5% | 0.00% | 0.0% |
Q4 2016 | $5,302,000 | +1800.4% | 188,986 | +1916.7% | 0.00% | – |
Q3 2016 | $279,000 | -56.1% | 9,371 | -70.1% | 0.00% | – |
Q2 2016 | $635,000 | +21.9% | 31,366 | +8.6% | 0.00% | – |
Q1 2016 | $521,000 | -35.6% | 28,888 | -5.9% | 0.00% | – |
Q4 2015 | $809,000 | +37.8% | 30,697 | +11.6% | 0.00% | – |
Q3 2015 | $587,000 | +1444.7% | 27,508 | +1830.4% | 0.00% | – |
Q2 2015 | $38,000 | – | 1,425 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |